Article Sidebar

Submitted
11 August 2017
Accepted
11 August 2017
Published
14 August 2017
Download
PDF
Statistic
Read Counter : 1307 Download : 1120

Main Article Content

Abstract

Endothelial dysfunction is an initial condition of atherosclerosis and other vascular diseases where one of the risk factors is hypercholesterolemia. Blood cholesterol levels is associated with an increase in the production of reactive oxygen species (ROS). The increasing of ROS production can cause increased oxidative stress which in turn resulting in endothelial dysfunction. Alpha lipoic acid (ALA) is one of the antioxidant compound that has been developed and studied. In this study we found that the use of ALA in Rattus norvegicus rats signifficantly lower the total cholesterol levels at dose 60 mg/kgBW (p=0.020). ALA also inhibit the expression of Monocyte Chemoattractant Protein-1 (MCP-1) at dose 60 mg/kgBW (p=0.044) and reduces the formation of Malondialdehyde (MDA) at dose 120 mg/kgBW (p=0.009), which is the initial stage of the atherogenic development and prognosis of events, thus, ALA can reduce the risk of further damage to the endothelium.

Keywords

hypercholesterolemia endothelial dysfunction MDA MCP-1 alpha lipoic acid

Article Details

How to Cite
Sari, D. P., Susilo, I., & Khotib, J. (2017). THE MECHANISM OF ALPHA LIPOIC ACID ON REDUCING THE MDA LEVEL AND MCP-1 EXPRESSION IN ENDOTHELIAL DYSFUNCTION OF HYPERCHOLESTEROLEMIA RAT (Rattus norvegicus) MODEL. Folia Medica Indonesiana, 52(3), 154–159. https://doi.org/10.20473/fmi.v52i3.5444
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Alipour M, Mohammadi M, Zarghami N, Ahmadiasi N (2006). Influence of chronic exercise on red cell antioxidant defense, plasma malondialdehyde and total antioxidant capacity in hypercholesterolemic rabbits. J Sports Sci Med 5, 682-691
  2. Amom Z, Zakaria Z, Mohamed J, Azlan A, Bahari H, Baharuldin MTH, Moklas MA, Osman K, Asmawi Z, Hassan MK (2008). Lipid lowering effect of antioxidant alpha-lipoic acid in experimental atherosclerosis. Journal of Clinical Biochemistry and Nutrition 43, 88–94
  3. Ayala A, Muñoz MF, Argüelles S (2014). Lipid peroxidation: production, metabolism, and signaling mechanism of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity 2014, 1-7
  4. Carrier B, Wen S, Zigouras S, Browne R.W, Li Z, Patel MS, Williamson DL, Rideout, TC (2014). Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese zucker rats. Plos One 9, 1-11
  5. Caterina RD, Massaro M, Libby P (2007). Endothelial function and disfunction. In: De Caterina R and Libby P (eds). Endothelial Dysfunctions and Vascular Disease, Massachusetts, Blackwell Publishing, p 7-16
  6. Drummond GR and Sobey CG (2014). Endothelial NADPH oxidases: which NOX to target in vascular disease? Trends in Endocrinology and Metabolism. 25, 452-460
  7. Gorąca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B (2011). Lipoic acid - biological activity and therapeutic potential. Pharmacol Rep 63, 849-858
  8. Higashi Y, Noma K, Yoshizumi M, Kihara Y (2009). Endothelial function and oxidative stress in cardiovascular disease. Circulation Journal 73, 411-418
  9. Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, Tsai KL, Sheu WH (2010). Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg 52, 1290-1300
  10. Li Y, Zhao Y, Yu W, Jiang S (2004). Scavenging ability on ROS of alpha-lipoic acid (ALA). Food Chemistry 84, 563–567
  11. Niki E (2014). Biomarkers of lipid peroxidation in clinical material. Biochim Biophys Acta 1840, 809-817
  12. Praticò D (2005). Antioxidant and endothelium protection. Atherosclerosis 181, 215-224
  13. Sena CM, Nunes E, Louro T, Proença T, Fernandes R, Boarder MR, Seiça RM (2008). Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. British Journal of Pharmacology 153, 894–906
  14. Shay (2009). Alpha-lipoic acid as a dietary supplement: molecular mechanism and therapeutic potential. Biochim Biophys Acta 1790, 1149-1160
  15. White GE, Channon KM, Greaves DR (2010). Chemokines and atherosclerosis: a critical assessment of therapeutic targets. In: George SJ and Johnson J (eds). Atherosclerosis: Molecular and Cellular Mechanisms, Weinheim, WILEY-VCH Verlag GmbH & Co, p 23-42
  16. WHO (2015). World Health Organization. Available from http://www.who.int/mediacentre/factsheets/fs317 /en/. Accessed April 03, 2015
  17. Wu JH, Wang QH, Li F, Shu YL, Chan CO, Mok DKW, Chan SW (2012). Suppression of diet-induced hypercholesterolemia by turtle jelly, a traditional chinese functional food, in rats. Evidence-Based Complementary and Alternative Medicine 2012
  18. Yang RL, Shi YH, Hao G, Li W, Le GW (2008). Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. Journal of Clinical Biochemistry and Nutrition 43, 154-158
  19. Ying Z, Kherada N, Farrar B, Kampfrath T, Chung Y, Simonetti O, Deiuliis J, Desikan R (2010). Lipoic acid effects on established atherosclerosis. NIH-PA Author Manuscript 86, 95–102
  20. Zulkhairi A, Zaiton Z, Jamalludin MJ, Sharida F, Mohd THB, Hasnah B, Nazmi HM, Khairul O, Zanariyah A (2008). Alpha lipoic acid posses dual antioxidant and lipid lowering properties in atherosclerotic-induced New Zealand white rabbit. Biomedicine and Pharmacotherapy 62, 716-722

Most read articles by the same author(s)